You are here
Family Bank: Cordlife India
Cordlife Sciences India Pvt. Limited is a member of the Cordlife Group Limited family of companies. Cordlife India is accredited by AABB and operates the most advanced cord blood laboratory in India.
Labs and Locations
219/2, A.J.C. Bose Road, Kolkata 700017
P.L. Deuty Road, off Diamond Harbour Road Bishnupur, 24 Parganas (S) West Bengal 743503, India
Cordlife Group Limited is listed on the Mainboard of the Singapore Exchange (SGX), and together with its subsidiaries, may be called "The Group". Cordlife Group Limited owns five cord blood banks in Singapore, Hong Kong, Indonesia, Philippines and India, and has a direct investment in China Cord Blood Corporation, one of the top banks in China. Cordlife also currently owns over 30% of Stemlife Malaysia. At present the laboratories in Singapore, Hong Kong, and India are accredited by AABB (formerly known as American Association of Blood Banks), meeting the gold standard of private cord blood banking. The Group now comprises of:
Cordlife Group Limited - Singapore
Cordlife (Hong Kong) Limited - Hong Kong & Macau
Cordlife Sciences India Pvt Limited - Kolkata, India
PT Cordlife Persada - Jakarta, Indonesia
Cordlife Medical Philippines, Inc. - Manila, Philippines
Cordlife has exclusive license to a patented technology, CellOptima™, which stores stem cells from the lining of the umbilical cord. This cord lining contains both Epithelial Stem Cells (EpSC) and Mesenchymal Stem Cells (MSC). Parents who are banking cord blood can add these enhanced services.
Cordlife India announced in April 2013 that they are the only bank in India that not only separates stem cells from cord blood and cord tissue, but also cultures them in the lab to grow an "expanded" cell count for therapeutic options.
Cordlife India claims to operate the most advanced cord blood laboratory in India. Their state-of-the-art facility is equipped with the latest and most modern equipment including Swiss-made Sepax®2, a U.S. FDA-cleared fully automated stem cell processing technology, placed within a clean-room infrastructure to ensure that stem cells are processed under the most sterile conditions. Cordlife India has a storage capacity for 150,000 units scalable by another few hundred thousands. Cordlife India is located within a natural calamity proof building, the facility is also built with continuous power backup and round-the-clock surveillance system.
The UN3373 certified collection kit contains a 250ml closed system blood bag that is pre-loaded with anti-coagulant (CPDA-1) to allow the caregiver to collect as much blood available. The kit also consists of two vials for umbilical cord storage and two 300gm foam bricks for temperature control. Compared to gel packs, these foam bricks are found to maintain temperature better.
Cordlife India's collection kit box is carefully designed with the most advanced tools available to ensure that the temperature within the kit box is maintained within an acceptable range and to minimize any adverse temperature fluctuation during harsh weather conditions.
Made of thermocol, the kit box is further coated with hard plastic and has vacuum between both materials as an added feature to help regulate temperature fluctuation. To ensure optimal temperature control, Cordlife uses two 300gm foam bricks which can be cooled a lot faster and retain coldness for much longer than conventional gel packs. Cordlife India's collection kit box has been validated at a temperature of 48° C at 100% humidity for 72 hours. The temperature logged inside within the box remained in a good range of 15-25° C.
Parents can also opt for temperature data logger service to validate that their baby's cord blood and umbilical cord were transported in optimum temperature condition during transportation to the laboratory. The data logger will provide detailed temperature captured within the box in intervals of 30 minutes. The logger will also provide the exact time taken to transport the kit from the hospital to Cordlife India's laboratory.
Cordlife India has partnered with the best transportation companies in the industry including Sequel Logistics, Jet Airways and Blue Dart, to help ensure safe and timely delivery of the collected cord blood and umbilical cord samples to its laboratory. Their UN3373 certified kit box is also X-ray free certified to prevent the samples from passing through X-ray checks during transportation.
Cordlife India is the first cord blood bank in India to process cord blood with the Sepax® 2, the world's only U.S. FDA-cleared fully automated processing technology for cord blood stem cells. Made by the Swiss company Biosafe, the Sepax® 2 can recover as high as 99.46% of Total Nucleated Cells (TNC) from cord blood; up to 57% cell count higher than other processing methods. It is also a functionally closed processing system which ensures the sterility of the cord blood by eliminating exposure to air contaminants. Cordlife also uses CellOptima™ and CellOptima Explant™ for cord lining processing in India.
Parents are provided with a cryopreservation certificate describing the test results obtained which include Total Nucleated Cell (TNC) count, total CD34+ cell count as well as presence or absence of bacteria and fungi. The maternal blood will be screened for HIV, HBV, HCV, HTLV, CMV, Syphillis, Malaria and additional tests as required by Drug Controller General of India (DCGI), AABB and other national regulatory bodies. Cordlife employs Nucleic Acid Testing (NAT) for screening of HIV and HCV in accordance with requirements of AABB.
Final cord blood storage is in 25ml multi-compartment cryobag with integral segments to allow for future testings. The cryobag is encased in a Teflon® coating pouch. Cordlife India stores the cord blood units in vapour phase of cryogenic nitrogen as a precaution to cross-contamination. All cord blood units are temporarily stored in quarantine tanks and will be moved to permanent tanks once the units have passed through necessary testings.
Cordlife India employs CellOptima™, a patented technology that can isolate epithelial stem cells and mesenchymal stem cells from the umbilical cord lining. For parents who have opted for cord lining storage in its original form, the tissue will be stored in multiple cryovials. For other parents who have opted for Epicord services (50 million or 500 million cell count), epithelial stem cells and mesenchymal stem cells will be expanded accordingly and stored in transplant ready condition.
Licensing & Accreditation
• Certified by Drug Controller General of India (DCGI)
• Accredited by AABB, one of the gold standards for cord blood banking
• ISO9001:2000 certified
• U.S. FDA registered
To date, Cordlife Group Limited and its associates have released cord blood units to more than 300 families to treat over 50 indications at more than 50 institutions globally.
Cordlife India provides a legally valid agreement to their clients, which has been notarized by local court*. The Company also provides guarantees for the following items:
• Full refund of the storage fee for its clients who use the specimen within 18 months of cryopreservation;
• Quality guarantee of US$30,000 if the sample loses its viability for any therapy;
• Guarantee of US$25,000 in case of a natural disaster and as a result, the sample cannot be used for therapy;
• Guaranteed transportation of sample to any part of the world within 10 working days (for cord blood) and 21 working days (for Expanded cord lining derived cells);
• Fully subsidized HLA typing and CFU for all Cordlife clients on use;
• Pro-rated waiver of storage fees until the end of contract tenure in case of any permanent disability or demise of the earning member of the family.
*Please refer to the service agreement for complete terms and conditions for the services.
Cordlife provides complimentary medical concierge service for clients. As a part of this service, Cordlife will give information regarding the doctor, hospital and travel options to the client who would requires a stem cell transplant or therapy. Cordlife will also provide US$25,000 directly to the concerned hospital on confirmation as financial aid to the family.
Cordlife has flexible plans which are priced affordably so that many families can benefit from stem cell storage.
Basic Plan: Rs 55,000, payable via EMI from as low as Rs900 per month (5 year plan)
Cordsure Plan: Rs65,000, payable via EMI from as low as Rs1,150 per month (5 year plan)
Explant: Rs99,000, payable via EMI from as low as Rs1,700 per month (5 year plan)
Epicord 50M: Rs1,47,000, payable via EMI from as low as Rs2,500 per month (5 year plan)
Epicord 100M: Rs3,14,000, payable via EMI from as low as Rs5,300 per month (5 year plan)
Cordlife also offers several additional services including:
• Data Logger Services
• Newborn metabolic screening for 110 disorders (Metascreen)
• Metabolic fingerprinting for women (Metascreen Eve)
Prices with Additional Services
Metascreen: Rs5,000 only